MOAT

MOAT identifies genomic regions with an unexpectedly high mutation count to detect potential cancer driver mutations using a non-parametric, permutation-based approach.


Key Features:

  • Non-parametric permutation testing: Uses permutation-based analysis that avoids explicit parametric modeling of background mutation rates.
  • Background mutation rate assumption: Assumes the background mutation rate (BMR) varies smoothly with genomic features rather than requiring cell-type-matched covariates.
  • Permutation targets: Performs large-scale random permutations of single-nucleotide variants or predefined target regions to assess mutation overburden.
  • GPU acceleration: Employs graphics processing unit (GPU) acceleration to expedite permutations, achieving an approximately 250-fold speed-up compared to traditional methods.
  • Robust burden analysis: Enables statistical assessment of mutation enrichment across genomic regions via extensive permutation sampling.

Scientific Applications:

  • Cancer genomics: Identification of regions with mutation overburden to discover potential driver mutations involved in oncogenesis.
  • Large-scale mutational landscape analysis: Application to large genomic datasets where covariate-independent burden testing and rapid computation are required.

Methodology:

MOAT applies non-parametric, permutation-based analysis by performing large-scale random permutations of single-nucleotide variants or target regions under the assumption that BMR varies smoothly with genomic features, and uses GPU acceleration to speed permutations (≈250-fold).

Topics

Details

License:
Unlicense
Maturity:
Mature
Cost:
Free of charge
Tool Type:
command-line tool
Operating Systems:
Linux, Windows, Mac
Added:
7/7/2019
Last Updated:
6/16/2020

Operations

Data Inputs & Outputs

Publications

Lochovsky L, Zhang J, Gerstein M. MOAT: efficient detection of highly mutated regions with the Mutations Overburdening Annotations Tool. Bioinformatics. 2017;34(6):1031-1033. doi:10.1093/bioinformatics/btx700. PMID:29121169. PMCID:PMC5860157.

Funding: - National Institutes of Health: 5U41HG007000-04

Documentation

Downloads